Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
about
Methods of Biotyping of Streptococcus mutans Species with the Routine Test as a Prognostic Value in Early Childhood Caries.Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital.Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience.Nutritionally variant streptococci bacteremia in cancer patients: a retrospective study, 1999-2014.A Case of Anterior Spinal Artery Syndrome Caused by Streptococcus mitis Endocarditis.
P2860
Q33862484-0EAB5B6A-9D3C-4860-9B5F-894B91B49345Q36096410-6D3F6D13-F798-4717-A6AE-3D9889D8462FQ36664056-9BCC83B1-C8D2-4277-9024-F76DC8E0311CQ38926289-208F7F1D-A70C-4E72-95F6-4B21CCC3F73EQ40106977-54AFB22A-8A51-4529-BD68-BBA409108001Q40220434-BE137E84-407B-4507-9209-6D473D5BE268Q52645916-65C2CE3B-3112-4731-A26E-EEAA1688F81E
P2860
Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Development and validation of ...... n neutropenic cancer patients.
@en
Development and validation of ...... n neutropenic cancer patients.
@nl
type
label
Development and validation of ...... n neutropenic cancer patients.
@en
Development and validation of ...... n neutropenic cancer patients.
@nl
prefLabel
Development and validation of ...... n neutropenic cancer patients.
@en
Development and validation of ...... n neutropenic cancer patients.
@nl
P2093
P2860
P356
P1476
Development and validation of ...... n neutropenic cancer patients.
@en
P2093
Jeffrey T Tarrand
Kenneth V I Rolston
Pranoti Sahasrabhojane
Robert E Lasky
Samuel A Shelburne
P2860
P304
P356
10.1093/CID/CIU260
P407
P577
2014-04-21T00:00:00Z